期刊文献+

CA199在卵巢成熟型畸胎瘤中的应用 被引量:3

下载PDF
导出
摘要 目的研究糖抗原199在卵巢成熟型畸胎瘤中应用的临床意义。方法选取2009年1月~2011年4月笔者所在医院妇产科收治进行手术并且术前进行CA199肿瘤标志物检查的卵巢成熟型畸胎瘤患者58例的临床资料进行回顾性分析。结果患者平均年龄(32.4±7.8)岁,58例中39例CA199升高,血清CA199平均值(96.5±183.2)U/mL,CA199升高占67.24%。结论 CA199在卵巢成熟畸胎瘤的诊断与鉴别诊断中具有一定的意义。CA199对检测卵巢成熟囊性畸胎瘤有一定意义,结合其影像学资料,可指导医生对肿瘤的探查及治疗,CA199是否可作为临床检测卵巢成熟型畸胎瘤的指标有待进一步研究证实。
出处 《中国医药科学》 2011年第12期122-122,共1页 China Medicine And Pharmacy
  • 相关文献

参考文献4

二级参考文献16

  • 1龚晓明,冷金花,郎景和,黄荣丽,刘珠凤,孙大为,朱兰.卵巢成熟畸胎瘤695例临床分析[J].中国医学科学院学报,2004,26(6):692-695. 被引量:51
  • 2郑怀美 苏应宽.妇产科学[M].北京:人民卫生出版社,1985.112.
  • 3连利娟,刘丹华,刘炽明,等.妇科肿瘤学[M].2版.北京:人民卫生出版社,1996:460-499.
  • 4Ishigam IS,Natsugoe S,Hokita S,et al.Clinical importance of preoperative carcino embryonic antigen and carbohydrate antigen 199 levels in gastric cancer[J].J Clin Gastro,2001,32(1):41-44.
  • 5Mann DV,Edwards R,Ho S,et al.Elevated tumor marker CA199:Clinical interpretation and influence of obstructive jaundice[J].Eur J Surg Ocol,2000,26:471-479.
  • 6Nanayakkara S, Ali S, Gilmour K. Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst[J]. J Obstet Gynaecol ,2007,27 ( 1 ) :96-97.
  • 7Atabekoglu C, Bozaci EA, Tezcan S. Elevated carbohydrate antigen 19-9 in a dermoid cyst[ J]. lnt J Gynaecol Obstet,2005,91( 3 ) :262-263.
  • 8Mikuni M, Makinoda S, Tanaka T, et al. Evaluation of tumor marker in ovarian dermoid cyst[ J ]. Nippon Sanka Fujinka Gakkai Zasshi, 1990,42 (5) :479-484.
  • 9Emin U, Tayfun G, Cantekin I, et al. Tumor markers in mature cystic teratomas of the cyats [J]. Arch Gyneeol Obstet, 2009, 279 : 145-147.
  • 10Coskun A, Kiran G, Ozdemir O. CA 19-9 can be a useful tumor marker in ovarian dermoid cysts[ J]. Clin Exp Obstet Gynecol, 2008,35(2) :137-139.

共引文献31

同被引文献53

  • 1Ustunyurt E, Gungor T, Iskender C. Tum- or markers in mature cystic tcratomas of the ovary[J]. Arch Gynecol Obstet,2009, 279:145-147.
  • 2Coskun A, Kiran G, Ozdemir O. CA 19-9 can be a useful tumor marker in ovarian dermoid cysts[J]. Clinical And Experi- mental Obstetrics&Gynecology, 2008, 35 (2):137-139.
  • 3Kikkawa F, Nawa A, Tamakoshi K, et al. Diagnosis of squamous cell carcinomaar-ising from mature cystic teratoma of the ovary[J]. Cancer, 199, 82(11):2249-2255.
  • 4Dede M, Gungor S, Yenen MC, et al.CA19-9 may have clinical significance in mature cystic teratomas of the ovary[J]. Int J Gynecol Cancer, 2006, 16(1): 189-193.
  • 5Ito K. CA19-9 in mature cystic teratom- a[J]. Hohoku Exp Med, 1994, 172(2): 133-138.
  • 6陈晨,李俊东,黄鹤,冯艳玲,王銮虹,陈亮.肿瘤标志物检测对卵巢成熟、未成熟畸胎瘤的诊断价值[J].癌症,2008,27(1):92-95. 被引量:45
  • 7Kataoka T, Watanabe Y, Hoshiai H. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma [J]. J Obstet Gynaecol Res,2012,38(8) :1071-1076.
  • 8Emin U,Taflun G,Cantekin I,et al. Tumor markers in mature cystic tera- tomas of the ovary[J]. Arch Gynecol Obstet ,2009,279(2) :145-147.
  • 9Dede M, Gungor S, Yenen MC, et al. CA19-9 may have clinical significance in mature cystic teratomas of the ovary [ J]. Int J Gyne- col Cancer, 2006, 16 (1): 189-193.
  • 10Coskun A, Kiran G, Ozdemir O. CA 19-9 can be a useful tumor marker in ovarian dermoid cysts [ J ]. Clin Exp Obstet Gynecol, 2008, 35 (2): 137-139.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部